Neuronetics (STIM) Total Non-Current Liabilities (2017 - 2026)
Neuronetics (STIM) reported Total Non-Current Liabilities of $108.3 million for Q1 2026, up 142.92% quarter-over-quarter from $44.6 million in Q2 2018.
Neuronetics (STIM) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 3 years of Total Non-Current Liabilities data on file, last reported at $108.3 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $108.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $108.3 million (changed N/A YoY), and the FY2017 annual result was $44.0 million, changed N/A from the prior year.
- Total Non-Current Liabilities advanced to $108.3 million in Q1 2026 per STIM's latest filing, from $44.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $108.3 million in Q1 2026 and troughed at $108.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | 108.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.31 Mn |
| Jun 30, 2018 | 44.59 Mn |
| Dec 31, 2017 | 43.98 Mn |